Date: 2014-07-04
Type of information: Capital increase
Company: Galapagos (Belgium)
Investors: Galapagos\' employee
Amount: €1.9 million
Funding type: warrant exercises
Planned used:
Others: * On July 4, 2014, Galapagos announced a share capital increase arising from warrant exercises. Since its inception in 1999, Galapagos has used warrant plans to incentivize personnel and management and have them share in the success of the company. Following warrant exercises during the exercise period from 18 June 2014 through 1 July 2014, Galapagos issued 181,507 new ordinary shares for a total capital increase (including issuance premium) of €1,862,301.54. No members of the Board of Directors or Executive Committee exercised warrants. To date, Galapagos\' total share capital amounts to €163,802,508.04; the total number of securities conferring voting rights is 30,280,344, which is also the total number of voting rights (the \"denominator\"), and all securities conferring voting rights and all voting rights are of the same category. The total number of rights (warrants) to subscribe to not yet issued securities conferring voting rights is 2,911,978, which equals the total number of voting rights that may result from the exercise of these warrants. Galapagos does not have any convertible bonds or shares without voting rights outstanding.
Therapeutic area:
